Elsevier Launches New Open Access Journal: Leukemia Research Reports

Informations

• Publié par: Elsevier
• Nombre de lectures: 8
• Langue: English

Extrait

Elsevier Launches New Open Access Journal: Leukemia Research Reports

PR Newswire OXFORD, England, November 22, 2012

OXFORD, England,November 22, 2012/PRNewswire/ --

A new forum for short communications ofclinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new open access, online journal,Leukemia Research Reports.

Leukemia Research Reports,a sister journal to the prestigious publicationLeukemia Research,will deliver timely information online to all health care professionals involved in basic and/or applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic m alignancies. It will fulfill this role by rapidly publishing a range of peer-reviewed short form papers, including brief communications, case reports, letters to the editors, images and debate articles.

The editors ofLeukemia Research Reportsare: Dr Suneel Mundle (Janssen Services LLC and Rush Medical College, Chicago, IL) and Dr Meir Wetzler (State University of New York at Buffalo School of Medicine and Roswell Park Cancer Center, Buffalo, NY).

The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies.Coverage will encompass the application of oncogenes, genomics (gene expression profiles, microRNAs), proteomics growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition articles are solicited on the rapidly growing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.

For more information or to submit an article, go tohttp://www.journals.elsevier.com/leukemia-research-reports. First articles published in the journal are now available online through ScienceDirect.

About Elsevier Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, includingThe LancetandCell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions includeScienceDirect,Scopus,Reaxys,ClinicalKeyandMosby's Nursing Suite, which enhance the productivity of science and health professionals, and theSciVal suiteandMEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost- effectively.

A global business headquartered in Amsterdam,Elsevieremploys 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact Rachel Garland Elsevier [phone] [e-mail]